Nephros Inc: Form 10-K for the period ended Dec 31, 2013
Filed with the SEC on Mar 28, 2014 and accepted by EDGAR at Mar 28, 2014, 14:29 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2013-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2013-01-01 to 2013-12-31 | $1.7m | us-gaap:SalesRevenueNet |
| Cost of revenue | 12 months2013-01-01 to 2013-12-31 | $898.0k | us-gaap:CostOfGoodsSold |
| Gross profit | 12 months2013-01-01 to 2013-12-31 | $842.0k | us-gaap:GrossProfit |
| Selling, general and administrative | 12 months2013-01-01 to 2013-12-31 | $3.1m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months2013-01-01 to 2013-12-31 | −$3.3m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2013-01-01 to 2013-12-31 | $94.0k | us-gaap:InterestExpense |
| Net income | 12 months2013-01-01 to 2013-12-31 | −$3.7m | us-gaap:NetIncomeLoss |
| Operating cash flow | 12 months2013-01-01 to 2013-12-31 | −$3.6m | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Capital expenditure | 12 months2013-01-01 to 2013-12-31 | $0 | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2013-12-31 | $579.0k | us-gaap:Cash |
| Current assets | At period end2013-12-31 | $988.0k | us-gaap:AssetsCurrent |
| Total assets | At period end2013-12-31 | $2.9m | us-gaap:Assets |
| Current liabilities | At period end2013-12-31 | $3.5m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2013-12-31 | $3.5m | us-gaap:Liabilities |
| Shareholders' equity | At period end2013-12-31 | −$610.0k | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001144204-14-018633. Last ingested by Listed: Nov 13, 2026, 16:20 ET. Listed shows no prices and gives no investment advice.